Literature DB >> 4566479

Immunity to neuroblastomas and melanomas.

K E Hellström, I Hellström.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4566479     DOI: 10.1146/annurev.me.23.020172.000315

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  6 in total

1.  Lymphocytotoxicity to tumor target cells and interference of serum factors or tumor antigen with lymphocytotoxicity in patients suffering from different stages of breast carcinoma.

Authors:  H Warnatz; D Lackner; E Eder; F Scheiffarth; M Gruhl; O Bischoff
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-02-25

2.  [Influence of autologous serum on leucocyte-migration-inhibition-test in melanomalignoma (author's transl)].

Authors:  J Fritz; K Grond
Journal:  Arch Dermatol Res       Date:  1977-04-27       Impact factor: 3.017

3.  Enhancement of mechanisms acting against mammary carcinoma: pancreatic trypsin inhibitor.

Authors:  A A Hakim
Journal:  Klin Wochenschr       Date:  1978-08-01

4.  [Cellular immunity in melanomalignome (author's transl)].

Authors:  J Fritz; K Grond; G P Tilz
Journal:  Arch Dermatol Res       Date:  1976-04-21       Impact factor: 3.017

5.  Melanotic neuroectodermal tumor of infancy: A case report and review of the surgical treatment.

Authors:  Yingqiu Cui; Zhe Mao; Chunhui Liao
Journal:  Oncol Lett       Date:  2014-11-04       Impact factor: 2.967

6.  Malignant glial neoplasms: definition of a humoral host response to tumor-associated antigen(s).

Authors:  K M Sheikh; M L Apuzzo; K R Kochsiek; M H Weiss
Journal:  Yale J Biol Med       Date:  1977 Jul-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.